Investigating cancer disparities in Black patients through genetic and environmental analysis
C07 - Societal, Ancestry, Molecular and Biological Analyses of Inequalities: SAMBAI
This study is looking into why prostate, breast, and pancreatic cancers tend to be more aggressive and happen earlier in Black patients, especially in West Africa, by exploring different factors like genetics and environment, and it aims to gather important information to help improve cancer care for these communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | King's College London NIH-funded |
| Lab location | 1 site (London, United Kingdom) |
| Project ID | NIH-11045099 on NIH RePORTER |
What this research studies
This research focuses on understanding why prostate, breast, and pancreatic cancers are more aggressive and occur earlier in Black patients, particularly in West Africa. The team will analyze genetic, environmental, and social factors that contribute to these disparities. By creating the SAMBAI Biobank and Data Repository, they aim to gather comprehensive data that reflects the experiences of marginalized populations. The research will involve collaboration with scientists from the US, Africa, and the UK to ensure a diverse and inclusive approach to cancer equity.
Who could benefit from this research
Good fit: Ideal candidates for this research include Black patients diagnosed with prostate, breast, or pancreatic cancers, particularly those from West African backgrounds.
Not a fit: Patients who do not identify as Black or who are not diagnosed with the specified cancers may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of cancer disparities, ultimately benefiting Black patients facing these aggressive cancers.
How similar studies have performed: Previous research has shown success in addressing cancer disparities through genetic and environmental analyses, making this approach promising.
Where this research is happening
London, United Kingdom
- King's College London — London, United Kingdom (Active)
Researchers
- Principal investigator: Kanth, Sheeba — King's College London
- Study coordinator: Kanth, Sheeba
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.